Background & Aims
Approximately one-third of individuals are likely to develop herpes zoster (HZ) in their lifetime, with 98% of these patients experiencing herpes zoster-associated pain (ZAP), which can lead to an increase in patient hospitalization rates. The aim of this study was to analyze the trend of medical expenditure for patients with ZAP and to explore its influencing factors.
Methods
We collected the medical expenditure data for inpatients diagnosed with ZAP from 2012 to 2021 at a tertiary hospital in Chongqing. We described the trend of medical costs over time and the trend of related subgroups, analyzed the composition of medical expenditures, and constructed a multiple linear regression model to investigate the factors affecting total inpatient costs. All expenditure data are reported in Chinese Yuan (CNY).
Results
We evaluated the total hospitalization costs of 822 patients, with an average total medical cost of CNY 10,413 per patient. Since 2012, patients’ total medical expenditures showed a trend of initial increase followed by a decrease, while the overall inpatient medical expenditures have shown a growth trend, with the largest proportion being drug expenditures. The results of the multiple linear regression model showed that the length of stay, age, treatment method, and whether the patient had hematological diseases were significantly associated with medical expenditures.
Conclusions
Since 2012, the overall medical expenses of patients with ZAP have shown an increasing trend. The duration of hospital stay, the presence of hematological diseases, age, and treatment methods are the most influential factors on medical expenditures.Therefore, it is necessary to take targeted measures to alleviate the economic burden on patients with ZAP.
References
1. J Zhang, F Xie, E Delzell, et al. Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases. Jama 2012;308(1):43-49.
2. LK Chen, H Arai, LY Chen, et al. Looking back to move forward: a twenty-year audit of herpes zoster in Asia-Pacific. Bmc Infect Dis 2017;17(1):213.
3. A Bardach, ML Cafferata, K Klein, et al. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean–a systematic review and meta-analysis. Pediatr Infect Dis J 2012;31(12):1263-68.
4. A Saguil, S Kane, M Mercado, R Lauters. Herpes Zoster and Postherpetic Neuralgia: Prevention and Management. Am Fam Physician 2017;96(10):656-63.
5. M Drolet, M Brisson, KE Schmader, et al. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. Cmaj 2010;182(16):1731-36.
6. TF Tsai, CA Yao, HS Yu, et al. Herpes zoster-associated severity and duration of pain, health-related quality of life, and healthcare utilization in Taiwan: a prospective observational study. Int J Dermatol 2015;54(5):529-36.
7. F Yang, S Yu, B Fan, et al. The Epidemiology of Herpes Zoster and Postherpetic Neuralgia in China: Results from a Cross-Sectional Study. Pain Ther 2019;8(2):249-59.
8. A Gater, M Uhart, R McCool, E Preaud. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. Bmc Public Health 2015;15:193.
9. CX Pan, MS Lee, VE Nambudiri. Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Ther Adv Vaccines Immunother 2022;10:965904759.
10. X Sun, Z Wei, H Lin, et al. Incidence and disease burden of herpes zoster in the population aged >/=50 years in China: Data from an integrated health care network. J Infect 2021;82(2):253-60.
11. J Tan, X Tang, Y He, et al. In-patient Expenditure Between 2012 and 2020 Concerning Patients With Liver Cirrhosis in Chongqing: A Hospital-Based Multicenter Retrospective Study. Front Public Health 2022;10:780704.
12. B Jiang, Q Wang, Z Wang, et al. Willingness to accept herpes zoster vaccines and the influencing factors in China. Bmc Infect Dis 2022;22(1):888.
13. Y Yang, T Chen, H Lin, et al. Incidence and economic burden of herpes zoster and its complications in immunocompromised adults: a retrospective cohort study in an eastern county, China. J Infect 2022;85(5):e155-57.
14. BT Liu, K Xue, BF Fan, Y Cui. [Interpretation of the expert consensus on the whole-process management of herpes zoster-associated pain]. Zhonghua Yi Xue Za Zhi 2022;102(40):3156-59.
15. NBOS China. China statistical yearbook 2022. Beijing: China Statistics Press 2022. In, 2022.Available online at: https://www.stats.gov.cn/tjsj/ndsj/2022/indexch.htm
16. HJ Forbes, K Bhaskaran, SL Thomas, et al. Quantification of risk factors for postherpetic neuralgia in herpes zoster patients: A cohort study. Neurology 2016;87(1):94-102.
17. S Karki, AT Newall, CR MacIntyre, et al. Healthcare Resource Utilisation Associated with Herpes Zoster in a Prospective Cohort of Older Australian Adults. Plos One 2016;11(8):e160446.
18. E Amodio, A Marrella, A Casuccio, F Vitale. Decline in hospitalization rates for herpes zoster in Italy (2003-2018): reduction in the burden of disease or changing of hospitalization criteria? Aging Clin Exp Res 2022;34(4):881-86.
19. AE Bardach, C Palermo, T Alconada, et al. Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis. Plos One 2021;16(8):e255877.
20. S Mao, C Fan, C Fu. The systematic review on the incidence of herpes zoster neuralgia in chronic patients. Chin Med J (Engl) 2022;102(40):3219-24.
21. RW Johnson, AS Rice. Clinical practice. Postherpetic neuralgia. N Engl J Med 2014;371(16):1526-33.
22. KM O’Connor, DS Paauw. Herpes zoster. Med Clin North Am 2013;97(4):503-22.
23. F Marra, K Parhar, B Huang, N Vadlamudi. Risk Factors for Herpes Zoster Infection: A Meta-Analysis. Open Forum Infect Dis 2020;7(1):a5.
24. S Frey, CR Blankart, T Stargardt. Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature. Pharmacoeconomics 2016;34(5):479-98.
Presenting Author
Lin Zhang
Poster Authors
Lin Zhang
Medical Center of Pain and Rehabilitation, Xinqiao Hospital, The Second Affiliated Hospital of Army
Lead Author
Topics
- Economics, Ethics, and Law